Fate Therapeutics, Inc.

NASDAQ: FATE
$43.28
+$1.08 (+2.6%)
Closing price January 14, 2022
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Analog Devices, Applied Materials, Comcast, Chipotle Mexican Grill, Grab, IBM, Johnson & Johnson, Lyft,...
Tuesday afternoon's analyst upgrades and downgrades included Fate Therapeutics, Livent, RealReal, SmileDirectClub and more.
Thursday's top analyst upgrades and downgrades included Dick’s Sporting Goods, Fate Therapeutics, Kimberly-Clark, Nordstrom, Roblox, TJX Companies and Zoom Video Communications.
A couple of Cathie Wood's ARK Invest funds bought over 240,000 shares of Fate Therapeutics on August 3.
One of Cathie Wood's Ark Invest funds bought over 530,000 shares of Fate Therapeutics on July 7.
Monday's top analyst upgrades and downgrades included Capital One, Etsy, Fiserv, Progessive, Splunk, Ulta Beauty and Visa.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Etsy, Fate Therapeutics, Intellia, Ionis, Monster Beverage and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Friday's top analyst upgrades and downgrades included AIG, Best Buy, Carvana, Dell Technologies, HP, L Brands, Monster Beverage, Twitter and Zscaler.
Wedbush took a closer look at some of the companies in its coverage universe that are set to present at ASCO and what the impact may be going forward.
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Ciena, CommVault Systems, Dollar General, JD.com, Kroger, Nucor, Target and Walmart.
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within...
Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm and...
The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this week in Orlando, Florida.
Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal...